Differences between screen-detected and interval breast cancers among BRCA mutation carriers-Reference-Cited by-同舟云学术

Differences between screen-detected and interval breast cancers among BRCA mutation carriers

Published:2019-01-23 Issue:1 Volume:175 Page:141-148
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Pilewskie Melissa^ORCID,Zabor Emily C.,Gilbert Elizabeth,Stempel Michelle,Petruolo Oriana,Mangino Debra,Robson Mark,Jochelson Maxine S.

Funder

NIH/NCI Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-018-05123-6.pdf

Reference39 articles.

1. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol Off J Am Soc Clin Oncol 25(11):1329–1333. https://doi.org/10.1200/JCO.2006.09.1066

2. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646. https://doi.org/10.1126/science.1088759

3. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112

4. National Comprehensive Cancer Network (NCCN) NCCN clinical practice guidelines in oncology. BRCA-related breast and/or ovarian cancer syndrome. https://www.nccn.org . Accessed 30 Aug 2018

5. American Cancer Society (2015) American Cancer Society recommendations for the early detection of breast cancer. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html . Accessed 3 July 2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Screening in Women With Dense Breasts: Current Status and Future Directions for Appropriate Risk Stratification and Imaging Utilization;Journal of Breast Imaging;2022-11-01

2. Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017);Breast Cancer Research and Treatment;2022-09-27

3. Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2;Cancers;2022-09-22

4. Implications of BRCA1, BRCA2 Gene in Overall Development and Prognosis of Breast Cancer;Breast Cancer: From Bench to Personalized Medicine;2022

5. Lapses in breast cancer screening for highly penetrant mutation carriers during pregnancy and lactation;Journal of Surgical Oncology;2021-12-02